MENU
ALNY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alnylam Pharmaceuticals (ALNY) Earnings Date & Reports
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
ALNY is expected to report earnings to fall 3.26% to $1.78 per share on October 29
Q3'26
Est.
$1.78
Q2'26
Beat
by $0.24
Q1'26
Beat
by $1.08
Q4'25
Beat
by $0.06
Q3'25
Beat
by $2.38
The last earnings report on July 30 showed earnings per share of $1.84, beating the estimate of $1.60. With 871.73K shares outstanding, the current market capitalization sits at 30.39B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of therapeutics based on RNA interference
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2500
Web
https://www.alnylam.com